bridge biotec, thinking beyond

menu.png

We are developing new nanotechnology driven medicines to safely treat and cure serious inflammatory diseases. Our safe new peptide medicines will switch off inflammation, opening the door to a $106 billion market. We are seeking Series A investment of $16m. Find out how you can contribute to this exciting new medical breakthrough here.

new effective and safe treatment for inflammation

Treating inflammation & inflammatory diseases, effectively & safely.

Bridge Biotec is developing a new peptide based nanotechnology that will change the way we treat inflammation and related diseases without any side effects.

Bridge Biotec Limited (“Bridge”) is developing novel therapeutics to safely treat life threatening and disabling inflammatory conditions such as inflammatory bowel disease (IBD), atopic dermatitis (AD, eczema), psoriasis and burns to cure serious inflammatory diseases.

Inflammation refers to a biological response to stimuli, interpreted by the body to have a potentially harmful effect.  In certain situations, such as after injury, inflammation is a normal response. However, inflammatory diseases result in the immune system attacking the body’s own cells or tissues and may cause abnormal inflammation resulting in chronic pain, swelling, stiffness and damage to normal tissues.

Bridge Biotec’s novel medicines are short proteins (“peptides”) that can be delivered into the human cell using a patented safe nano-polymer delivery technology which have been shown to switch off inflammation in a recognised cellular model.  These short peptides, that will be broken down into simple and naturally occurring amino acids, are highly active and exquisitely specific inflammation blockers, so only tiny doses will be required to cure serious inflammatory diseases.

Bridge is an ambitious company aiming to be revenue-generating within 18 months.

READ ABOUT OUR RESEARCH 

FIND OUT HOW YOU CAN INVEST IN OUR TECHNOLOGY

donate to assist our research

If you would like to make a donation to Bridge Biotec to help us advance our research into inflammation treatments, please use the donate button below.

 donate-button.png

talk to bridge biotec about investing in our work

If you would like to speak to us in detail about investing, tax benefits, donating or assisting us in any way at all, please contact us via the details below and we will get back to you as soon as possible.

talk-button.png

youtube bridge biotecbridge biotec facebookbridge biotec twitterbridge biotec linkedin

Contact

Email: contact@bridgebiotec.com
UK: +44 (0) 20 3097 1979
US: +1 212 863 9902

©2018 Bridge Biotec Ltd.

The BioHub at Alderley Park
Mereside, Alderley Park
Macclesfield
SK10 4TG